期刊
MEDCOMM
卷 3, 期 3, 页码 -出版社
WILEY
DOI: 10.1002/mco2.163
关键词
administration routes; cancer; controlled drug delivery; nanomedicines
资金
- Tata Innovation Fellowship [BT/HRD/35/01/02/2020]
Nanomedicine is a powerful tool for developing innovative drug carriers with greater efficacy and fewer side effects in cancer treatment. This review discusses different nanocarriers, their routes of administration, and the effect of dimensional properties on chemotherapy. It also highlights emerging therapies, such as photothermal, photodynamic, immunotherapy, chemodynamic, and gas therapy, and their advantages compared to conventional molecular anticancer therapies.
The higher prevalence of cancer is related to high rates of mortality and morbidity worldwide. By virtue of the properties of matter at the nanoscale, nanomedicine is proven to be a powerful tool to develop innovative drug carriers with greater efficacies and fewer side effects than conventional therapies. In this review, different nanocarriers for controlled drug release and their routes of administration have been discussed in detail, especially for cancer treatment. Special emphasis has been given on the design of drug delivery vehicles for sustained release and specific application methods for targeted delivery to the affected areas. Different polymeric vehicles designed for the delivery of chemotherapeutics have been discussed, including graft copolymers, liposomes, hydrogels, dendrimers, micelles, and nanoparticles. Furthermore, the effect of dimensional properties on chemotherapy is vividly described. Another integral section of the review focuses on the modes of administration of nanomedicines and emerging therapies, such as photothermal, photodynamic, immunotherapy, chemodynamic, and gas therapy, for cancer treatment. The properties, therapeutic value, advantages, and limitations of these nanomedicines are highlighted, with a focus on their increased performance versus conventional molecular anticancer therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据